KIMBERLY COMEAU: Open Payments
NPI 1568415180 · SWAMPSCOTT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,308 in 270 payments from 18 companies in 2025. Trend: 2023 $36,667 · 2024 $27,593 · 2025 $18,308
Speaker / faculty: $11,825Food & beverage: $5,271Travel & lodging: $1,114Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $13,636 |
| ABBVIE INC. | 41 | $689 |
| UCB, Inc. | 29 | $569 |
| Galderma Laboratories, L.P. | 32 | $443 |
| GENZYME CORPORATION | 16 | $401 |
| Lilly USA, LLC | 16 | $372 |
| Incyte Corporation | 18 | $318 |
| Regeneron Healthcare Solutions, Inc. | 12 | $310 |
| PFIZER INC. | 4 | $244 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $208 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, TALTZ, OPZELURA, CIBINQO.
Industry payments across MA — which companies pay providers there.
